Spanish Supreme Court provides clarity on patent limitations during invalidity proceedings
Written By
In a recent judgment, the Supreme Court clarifies the procedural practice for defendants to raise a patent limitation during invalidity proceedings. In this particular case, the invalidity related to addition of subject matter and lack of inventive step on the patent of the Tiotropium drug.
Background and summary of the case
The case was brought in 2012 by Laboratorios Liconsa S.A. (“Liconsa”) against Boehringer Ingelheim Pharma GmbH &Co (“Boehringer”) before the Barcelona Patent court.
Liconsa filed invalidity proceedings for revocation of Boehringer's patent EP 1.379.220 , validated in Spain under number
Full article available on PatentHub
Latest insights
More Insights
The Law Commission presents its proposals on reform of the Arbitration Act 1996
Oct 03 2023
Pet-ential competition concerns in the vet industry? UK watchdog launches review into the veterinary services market
Oct 02 2023
Attorney-General's Privacy Review Report: Australian government response flags significant changes on the horizon
Sep 29 2023